UPClytics
ENDE
Sign inStart trial
View all cases

UPC CFI 642/2024

Oct 31, 2024·EP3167888 Unitary patent · TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT

Follow
Case details
Status
Case Closed (Withdrawn)
Action
Revocation
Category
Main revocation action
Parties
Claimants
Representatives
Respondents
Representatives
Division
Milan CD
Judges
Technology
  • Chemistry
    Biotechnology · Pharmaceuticals
Language
English
EPO Opposition
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Patent revokedMedian days to first decision
All UPC37% (34/91)124
Milan CDLockedLocked
Judge Andrea PostiglioneLockedLocked
Judge Marije KnijffLockedLocked
Judge Rudi GoedeweeckLockedLocked

At the UPC: Amgen Group (19 cases)·AstraZeneca Group (13 cases)

Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patent

7 other defendants litigating the same or a related patent

UPC CoA 744/2025·UPC CFI 674/2025·UPC CFI 51/2025·UPC CoA 402/2024·UPC CoA 405/2024 and 2 more

Start a free trial to see how each one ended.

More cases: Milan CD·2024

Decisions
  • —
    revocation

    Summary: 1. The withdrawal of the revocation action (ACT_59173/2024, UPC_CFI_642/2024) is allowed at the application of the Claimants and with the consent of the Defendant.

Documents
Show all 390 documents
Document titleDatePublic
Case closed2025-12-04Not public
Decision2025-12-03Not public
Decision2025-12-03Public
Cover sheet2025-11-26Not public
Further pleadings2025-11-26Not public
Receipt2025-11-26Not public
Cover sheet2025-11-25Not public
Application document Claimant2025-11-25Not public
Receipt2025-11-25Not public
Cover sheet2025-11-25Not public